Synaptogenix Inc (SNPX)

[Cyosol]

We'll just have to agree to disagree then.

If you look at older analyst reports about this company you'll see that they were all wrong, and they would still be wrong if the drug had succeeded because their price target would've been set too low.

Those reports are still included in the ibox though because they contain interesting information that investors can use to get a more informed opinion about the company, and hopefully they will combine it with other data and opinions to get a better understanding of how to trade this stock in the best way possible.

Information from multiple sources is key, and restricting yourself to what an analyst says means you're restricting the amount of information you collect.